Project description
An innovative platform for faster, safer and cost-efficient drug discovery
Fields of science
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- natural sciencesbiological sciencesmicrobiologyvirology
- social scienceseconomics and businesseconomicshealth economicseconomic impact of epidemics
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
SIGNIA THERAPEUTICS
Net EU contribution
€ 50 000,00
Address
L'atrium 43 Boulevard Du 11 Novembre 1918
69100 Villeurbanne
France
69100 Villeurbanne
France
See on map
Region
Auvergne-Rhône-Alpes Rhône-Alpes Rhône
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 21 429,00